Bicara Therapeutics Raises $150M Through Stock and Warrant Offering
Bicara Therapeutics raises $150M through stock and warrant offering to fund lead drug candidate development, expand manufacturing, and build commercial infrastructure.
BCAXEGFRpublic offering